Macular serpiginous choroiditis.

dc.contributor.authorSahu, Dinesh Ken_US
dc.contributor.authorRawoof, Abdulen_US
dc.contributor.authorSujatha, Ben_US
dc.date.accessioned2002-09-03en_US
dc.date.accessioned2009-05-29T08:27:58Z
dc.date.available2002-09-03en_US
dc.date.available2009-05-29T08:27:58Z
dc.date.issued2002-09-03en_US
dc.description.abstractPURPOSE: To report a variant form of serpiginous choroiditis, that initially or predominantly involved the macular area. METHODS: Nine eyes of 6 patients with the macular form of serpiginous choroiditis were evaluated clinically and angiographically in a longitudinal fashion for a period of 12-36 months. The active stage and the recurrences were treated by oral and periocular cortico steroids; and two patients were supplemented with oral azathioprine. Most of these patients were referred to our center with varied diagnoses. RESULTS: In this group, 4 were male and 2 were female with an average age of 30.5 years. Three patients had bilateral macular lesions, two had typical serpiginous choroiditis in the fellow eye and the remaining one had unilateral macular involvement alone. The initial visual acuity was 6/60 or less in 60% eyes whereas the final visual acuity was 6/18 or better in 66% eyes. Angiographic findings were typical of serpiginous choroiditis characterised by early hypofluorescence followed by leakage and staining of the borders and the lesion itself without any evidence of choroidal ischaemia or retinal vascular abnormalities. CONCLUSION: The macular variant of serpiginous choroiditis can mimic many other macular pathologic lesions, thus posing a diagnostic dilemma. Because of its relentless destructive course, early diagnosis and prompt treatment is required to prevent sight-threatening complications.en_US
dc.description.affiliationRetina-Vitreous Services, Manipal Hospital, Airport Road, Bangalore-560 017, India. dineshsahukmhb@vsnl.neten_US
dc.identifier.citationSahu DK, Rawoof A, Sujatha B. Macular serpiginous choroiditis. Indian Journal of Ophthalmology. 2002 Sep; 50(3): 189-96en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/70506
dc.language.isoengen_US
dc.source.urihttps://www.ijo.inen_US
dc.subject.meshAdolescenten_US
dc.subject.meshAdulten_US
dc.subject.meshAnti-Inflammatory Agents --therapeutic useen_US
dc.subject.meshAzathioprine --therapeutic useen_US
dc.subject.meshChoroid --blood supplyen_US
dc.subject.meshChoroiditis --drug therapyen_US
dc.subject.meshDiagnosis, Differentialen_US
dc.subject.meshFemaleen_US
dc.subject.meshFluorescein Angiographyen_US
dc.subject.meshHumansen_US
dc.subject.meshImmunosuppressive Agents --therapeutic useen_US
dc.subject.meshInjectionsen_US
dc.subject.meshMacula Lutea --pathologyen_US
dc.subject.meshMaleen_US
dc.subject.meshMiddle Ageden_US
dc.subject.meshPigment Epithelium of Eye --pathologyen_US
dc.subject.meshPrednisolone --therapeutic useen_US
dc.subject.meshPrognosisen_US
dc.subject.meshRecurrenceen_US
dc.subject.meshRetrospective Studiesen_US
dc.subject.meshTriamcinolone --administration & dosageen_US
dc.subject.meshVisual Acuityen_US
dc.titleMacular serpiginous choroiditis.en_US
dc.typeJournal Articleen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description: